First 10 runs free
    Intelligence Feed event · Capital · 2026-11-07

    Oracle Completes $20B Split Capital Raise via $10B Stock and $10B Debt

    Question

    Oracle Completes $20B Split Capital Raise via $10B Stock and $10B Debt

    Direct answer

    Oracle has executed a rapid $20 billion balance-sheet expansion, raising $10 billion through equity issuance priced at $116 per share alongside $10 billion in institutional bond sales. The entire process was finalized in five trading sessions. The equity placement introduces approximately 3% net dilution to shareholders. The $10 billion bond placement tests primary corporate bond absorption amid an elevated benchmark rate environment.

    Original publisher
    Market Ontology
    Evidence through
    2026-11-07
    Published
    2026-11-07
    Revision
    1 · 2026-11-08

    Cite as: Market Ontology, “Oracle Completes $20B Split Capital Raise via $10B Stock and $10B Debt”, revision 1, evidence through 2026-11-07. https://marketontology.com/market-events/2026-11-07/oracle-completes-20b-split-capital-raise-via-10b-stock-and-10b-debt-b6e781

    CAPITAL
    Oracle Completes $20B Split Capital Raise via $10B Stock and $10B Debt
    Oracle has executed a rapid $20 billion balance-sheet expansion, raising $10 billion through equity issuance priced at $116 per share alongside $10 billion in institutional bond sales. The entire process was finalized in five trading sessions. The equity placement introduces approximately 3% net dilution to shareholders. The $10 billion bond placement tests primary corporate bond absorption amid an elevated benchmark rate environment.
    ORCLTLT
    Impact
    77
    YESTERDAY
    SIG
    89%
    ORCLTLT
    Oracle Completes $20B Split Capital Raise via $10B Stock and $10B Debt
    Oracle has executed a rapid $20 billion balance-sheet expansion, raising $10 billion through equity issuance priced at $116 per share alongside $10 billion in institutional bond sales. The entire process was finalized in five trading sessions. The equity placement introduces approximately 3% net dilution to shareholders. The $10 billion bond placement tests primary corporate bond absorption amid an elevated benchmark rate environment.
    → Absorbing $10 billion in corporate debt issuance increases primary investment-grade credit supply, while equity dilution at $116 per share anchors near-term ORCL valuation multiples.
    Impact
    Oracle has executed a rapid $20 billion balance-sheet expansion, raising $10 billion through equity issuance priced at $116 per share alongside $10 billion in institutional bond sales. The entire process was finalized in five trading sessions. The equity placement introduces approximately 3% net dilution to shareholders. The $10 billion bond placement tests primary corporate bond absorption amid an elevated benchmark rate environment.
    Affected
    ORCLTLT
    Transmission
    Absorbing $10 billion in corporate debt issuance increases primary investment-grade credit supply, while equity dilution at $116 per share anchors near-term ORCL valuation multiples.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    ORCLequity dilution at $116 per share offsetting balance-sheet liquidityMixed1-5dOracle sold $10B in stock at $116/share, adding ~3% dilution.
    TLTlarge corporate bond supply concessions impacting high-grade credit and duration pricingWatch1-5dOracle priced $10B in corporate bonds in five days.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    TLTWatch81.76 2026-11-04PendingPendingPending
    ORCLMixed126.19 2026-11-03PendingPendingPending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    Find trades for this development

    Screen tradable expressions of this catalyst against your horizon and constraints. Nothing is submitted without your review.

    First 10 runs free

    First 10 runs free

    See today's live cards

    Public pages are published 24 hours after the product shows them. The product shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open live cards